184
Views
6
CrossRef citations to date
0
Altmetric
Original Investigations

Treatment of unipolar psychotic depression: The use of evidence in practice guidelines

, &
Pages 409-415 | Received 31 Jan 2007, Published online: 08 Dec 2009

References

  • Agree Collaboration. 2001. Appraisal of Guidelines for Research & Evaluation (AGREE) Instrument. www.agreecollaboration.org.
  • American Psychiatric Association. 2000. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000;157(Suppl 4)1–45
  • Anton RF, Jr, Burch EA, Jr. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry 1990; 147: 203–208
  • Bauer, M, Whybrow, PC, Angst, J, Versiani, M, Möller, HJ. 2002. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Parts 1 and 2. World J Biol Psychiatry, 3:5–43, 69–86.
  • Bellini L, Gasperini M., Gatti F, Franchini L, Smeraldi E. A double blind study with fluvoxamine vs. desipramine combined with placebo or haloperidol in delusional depression. Crit Issues Treat Affect Disord 1994; 9: 32–36
  • Brown RP, Frances A, Kocsis JH, Mann JJ. Psychotic vs. nonpsychotic depression: comparison of treatment response. J Nerv Ment Dis 1982; 170: 635–637
  • Bruijn JA, Moleman P, Mulder PG, et al. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacology 1996; 127: 231–237
  • Bruijn JA, Moleman P, Mulder PHG, Broek van den WW. Treatment of mood-congruent psychotic depression with imipramine. J Affect Disord 2001; 66: 165–174
  • CANMAT Depression Workgroup. 2001. Clinical guidelines for the treatment of depressive disorders. Can J Psychiatry, 46(Suppl 1)5–90.
  • Charney DS, Nelson JC. Delusional and nondelusional unipolar depression: further evidence for distinct subtypes. Am J Psychiatry 1981; 138: 328–333
  • Dutch National Steering Committee Multidisciplinary Guideline Development Mental Health (Landelijke stuurgroep Multidisciplinaire Richtlijnontwikkeling in de GGZ). 2005. Multidisciplinary guideline depression. Trimbos-instituut.www.trimbos.nl/producten. ISBN 9052535078.
  • Kaskey GB, Nasr S, Meltzer HY. Drug treatment in delusional depression. Psychiatry Res 1980; 1: 267–277
  • Miller AL, Crismon ML, Rush AJ, et al. The Texas medication algorithm project: clinical results for schizophrenia. Schizophr Bull 2004; 30: 627–647
  • Minter RE, Manderl MR. A prospective study of the treatment of psychotic depression. Am J Psychiatry 1979; 136: 1470–1472
  • Mulsant BH, Sweet RA, Rosen J, et al. A double-blind randomised comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life. J Clin Psychiatry 2001; 62: 597–604
  • National Institute for Clinical Excellence. 2004. Depression: management of depression in primary and secondary care (Clinical Guideline 23). London: NICE.
  • Parker G, Roy K, Hadzi-Pavlovic D, Pedic F. Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disord 1992; 24: 17–24
  • Rothschild AJ, Phillips KA. Selective serotonin reuptake inhibitors and delusional depression (Letter). Am J Psychiatry 1999; 156: 977–978
  • Rothschild AJ, Samson JA, Besette MP, Carter-Campbell JT. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry 1993; 54: 338–342
  • Rothschild AJ, Bates KS, Boehringer KL, Syed A. Olanzapine response in psychotic depression. J Clin Psychiatry 1999; 60: 116–118
  • Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guideline Team for Depression. 2004. Australian and New Zealand clinical practice guideline for the treatment of depression. Aust NZ J Psychiatry, 38: 389–407.
  • South African Society of Psychiatrists (SASOP). Year unknown. Algorithms for the more prevalent psychiatric conditions.
  • Spiker DG, Hanin I, Perel JM, Cofsky JE, Rossi AJ, Sorisio D. Pharmacological treatment of delusional depressives. Psychopharmacol Bull 1982; 18: 184–1186
  • Spiker DG, Cofsky WJ, Dealy RS, et al. The pharmacological treatment of delusional depression. Am J Psychiatry 1985; 42: 430–436
  • Trivedi, MH, Shon, S, Crismon, ML, Key, T. 2000. Guidelines for Treating Depressive Disorder. Texas Implementation of Medication Algorithms (TIMA) University of Texas Southwestern Medical School at Dallas.
  • Weinmans S, Janssen B, Gaebel W. Guideline adherence in medication management of psychotic disorders: an observational multisite hospital study. Acta Psychiatr Scand 2005; 112: 18–25
  • Wijkstra, J, Lijmer, J, Balk, FJ, Geddes, JR, Nolen, WA. 2005. Pharmacological treatment for psychotic depression. The Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD004044.pub2. DOI: 10.1002/14651858.CD004044.pub2.
  • Wijkstra J, Lijmer J, Balk FJ, Geddes JR, Nolen WA. Pharmacological treatment for unipolar psychotic depression: systematic review and meta-analysis. Br J Psychiatry 2006; 188: 410–415
  • Zanardi R, Franchini L, Gasperini M, Perez J, Smeraldi E. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry. 1996; 153: 1631–1633
  • Zanardi R, Franchini L, Gasperini M, Lucca A, Smeraldi E, Perez J. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study. J Clin Psychopharmacol 1998; 18: 441–446
  • Zanardi R, Franchini L, Serretti A, Perez J, Smeraldi E. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. J Clin Psychiatry 2000; 61: 26–29

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.